Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [658]
News [1456]
Articles [246]
Editorials [9]
Conferences [82]
elearning [17]
HPV-targeted adoptive T Cell therapy for advanced cervical cancer
Dr Christian Hinrichs - Center for Cancer Research, Bethesda, USA
HPV-targeted adoptive T Cell therapy for advanced cervical cancer ( Dr Christian Hinrichs - Center for Cancer Research, Bethesda, USA )
2 Jun 2014
HPV-targeted adoptive T Cell therapy may provide a new personalised strategy...
Dr Christian S. Hinrichs - Center for Cancer Research, Bethesda, US
HPV-targeted adoptive T Cell therapy may provide a new personalised strategy for advanced cervical cancer ( Dr Christian S. Hinrichs - Center for Cancer Research, Bethesda, US )
2 Jun 2014
Comment: HPV-targeted adoptive T cell therapy may provide a new strategy for...
Dr Steven O'Day - Beverly Hills Cancer Center, Los Angeles, USA
Comment: HPV-targeted adoptive T cell therapy may provide a new strategy for advanced cervical cancer ( Dr Steven O'Day - Beverly Hills Cancer Center, Los Angeles, USA )
2 Jun 2014
Lower-dose radiation safe for certain lower-risk, HPV-positive head and neck...
Prof Anthony Cmelak - Vanderbilt-Ingram Cancer Center, Nashville, USA
Lower-dose radiation safe for certain lower-risk, HPV-positive head and neck cancers ( Prof Anthony Cmelak - Vanderbilt-Ingram Cancer Center, Nashville, USA )
2 Jun 2014
ASCO 2014 roundup
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ASCO 2014 roundup ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
2 Jun 2014
Targeted drug combo, cediranib plus olaparib, significantly increases...
Dr Joyce Liu - Dana-Farber Cancer Institute, Boston, USA
Targeted drug combo, cediranib plus olaparib, significantly increases progression-free survival in recurrent ovarian cancer ( Dr Joyce Liu - Dana-Farber Cancer Institute, Boston, USA )
31 May 2014
Cediranib plus olaparib significantly increases PFS in recurrent ovarian cancer
Dr Joyce Liu - Dana-Farber Cancer Institute, Boston, USA
Cediranib plus olaparib significantly increases PFS in recurrent ovarian cancer ( Dr Joyce Liu - Dana-Farber Cancer Institute, Boston, USA )
31 May 2014
Role of AORTIC in dealing with rising cancer rates in Africa
North American Vice president of AORTIC
Role of AORTIC in dealing with rising cancer rates in Africa ( North American Vice president of AORTIC )
1 May 2014
Role of genomics in assessing risk, especially in ovarian cancer
Dr Thomas Sellers - Moffitt Cancer Center, Tampa, USA
Role of genomics in assessing risk, especially in ovarian cancer ( Dr Thomas Sellers - Moffitt Cancer Center, Tampa, USA )
1 May 2014
Prevention of cervical cancer through control of HPV virus
Dr Margaret Stanley - Department of Pathology, University of Cambridge...
Prevention of cervical cancer through control of HPV virus ( Dr Margaret Stanley - Department of Pathology, University of Cambridge, Cambridge, United Kingdom )
11 Apr 2014
The global control and prevention of cervical cancer caused by HPV
Prof Thomas Broker - University of Alabama, Birmingham, USA
The global control and prevention of cervical cancer caused by HPV ( Prof Thomas Broker - University of Alabama, Birmingham, USA )
11 Apr 2014
Recent advances in surgery, radiotherapy and targeted treatment for cervical...
Dr Raj Kerkar - Tata Memorial Hospital, Mumbai, India
Recent advances in surgery, radiotherapy and targeted treatment for cervical cancer ( Dr Raj Kerkar - Tata Memorial Hospital, Mumbai, India )
4 Dec 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation